Colgate-Palmolive Company

Colgate-Palmolive Company (CL) Market Cap

Colgate-Palmolive Company has a market capitalization of $66.07B.

Financials based on reported quarter end 2025-12-31

Price: $82.35

0.54 (0.66%)

Market Cap: 66.07B

NYSE · time unavailable

CEO: Noel R. Wallace

Sector: Consumer Defensive

Industry: Household & Personal Products

IPO Date: 1973-05-02

Website: https://www.colgatepalmolive.com

Colgate-Palmolive Company (CL) - Company Information

Market Cap: 66.07B · Sector: Consumer Defensive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Analyst Sentiment

62%
Buy

Based on 43 ratings

Analyst 1Y Forecast: $90.96

Average target (based on 5 sources)

Consensus Price Target

Low

$79

Median

$94

High

$102

Average

$94

Potential Upside: 13.8%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 Colgate-Palmolive Company (CL) — Investment Overview

🧩 Business Model Overview

Colgate-Palmolive Company operates as a leading global consumer products company, primarily engaged in the production, distribution, and sale of oral care, personal care, home care, and pet nutrition products. The company’s core offerings include toothpaste, toothbrushes, mouthwash, soaps, shampoos, deodorants, dish detergents, surface cleaners, and pet foods, among others. Colgate’s brands are widely recognized and distributed across both developed and emerging markets, with a customer base that spans individual consumers, retailers, wholesalers, and veterinary professionals. Its products form part of daily routines worldwide, reinforcing strong brand affinity and consumer touchpoints.

💰 Revenue Model & Ecosystem

Colgate-Palmolive generates revenue through a diversified product portfolio, with substantial contributions from mass-market consumables. Its primary revenue stems from recurring consumer purchases of oral, personal, and home care products through large retail channels and e-commerce, benefiting from high-frequency consumption cycles. The company also operates in the pet nutrition segment via its Hill’s Pet Nutrition brand, selling through pet specialty retailers, veterinarians, and online platforms. While the business is predominantly consumer-focused, the pet nutrition unit introduces elements of professional recommendation dynamics, particularly among veterinary partners. Colgate leverages innovation, brand extensions, and geographic diversification to strengthen multi-stream revenue and deepen its channel ecosystem.

🧠 Competitive Advantages

  • Brand strength: Colgate-Palmolive commands globally trusted brands, especially in oral care, fostering consumer loyalty and premium positioning.
  • Switching costs: Everyday products often become habitual purchases, making consumer switching less frequent absent strong incentives.
  • Ecosystem stickiness: Integrated product lines across oral, personal, and home care—and veterinary networks in pet nutrition—enable cross-selling and reinforce enduring customer relationships.
  • Scale + supply chain leverage: Extensive global footprint and operational scale empower Colgate to negotiate with retailers, optimize production, and respond rapidly to shifting consumer dynamics.

🚀 Growth Drivers Ahead

Several long-term catalysts underpin Colgate’s growth strategy. First, expansion in emerging markets offers significant headroom as rising incomes and urbanization fuel demand for branded hygiene and pet nutrition products. Ongoing investment in product innovation—such as premium oral care solutions and natural ingredient lines—responds to evolving consumer preferences. E-commerce adoption provides new distribution avenues, while direct-to-consumer initiatives promote deeper relationships. In pet nutrition, increasing pet ownership trends, premiumization, and scientific/therapeutic formulations further support multi-year growth. Strategic acquisitions and geographic portfolio optimization remain potential levers for accelerating scale and market share.

⚠ Risk Factors to Monitor

Colgate-Palmolive operates in intensely competitive markets, facing global and local rivals that can exert pricing pressure and challenge market share. The company is exposed to commodity cost volatility, which can squeeze margins given the price-sensitive nature of many products. Shifting consumer behavior—such as private label adoption, sustainability preferences, and regulatory scrutiny of ingredients—introduces both operational and reputational risks. Regulatory environments, particularly concerning labeling and product safety, may evolve, requiring ongoing adaptation. Supply chain disruptions, geopolitical risks, and currency fluctuations can also impact performance.

📊 Valuation Perspective

The market tends to value Colgate-Palmolive at a premium relative to many consumer staples peers, reflecting its resilient cash flows, global brand equity, and historically stable performance. This valuation outlook is underpinned by the company’s consistent dividend policy, defensive business profile, and broad geographic and category diversification. However, this premium also implies that investors often expect steady execution and continued growth, making the shares sensitive to changes in competitive dynamics or earnings quality.

🔍 Investment Takeaway

Colgate-Palmolive represents a classic defensive investment, underpinned by brand leadership, habitual product use, and geographic reach across both mature and growth markets. The bull case emphasizes its durable moat in oral care, track record of innovation, and ability to tap emerging market growth and pet nutrition trends. Conversely, the bear case considers increasing competition, vulnerability to input costs, and evolving consumer expectations that may erode brand power or require elevated investment. Overall, Colgate-Palmolive remains a core holding candidate in the consumer staples sector for investors seeking stability balanced with incremental growth opportunity.


⚠ AI-generated research summary — not financial advice. Validate using official filings & independent analysis.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"In the most recent quarter, Colgate-Palmolive reported a revenue of $5.23 billion, with a net income loss of $37 million and an EPS of -$0.046. The net margin reflects this loss, indicating a challenging period. Free cash flow remained strong at approximately $1.28 billion, demonstrating robust underlying cash generation. Despite the subdued revenue performance, the year-over-year growth challenges are evident. Growth for CL has been stagnant, with notable pressure on profitability indicated by the negative net margin. The efficiency in generating operating cash flow points to healthy operational management, but profitability remains a concern. CL continues to maintain liquidity with ending cash of $1.29 billion, and a strong free cash flow balance that supports substantial dividends of $0.52 per share and share buybacks worth $406 million. The company's leverage is high, with net debt standing at $6.7 billion and a debt-to-equity ratio indicating significant reliance on external financing. Analyst sentiment towards CL is cautiously optimistic with a consensus price target of $91.8. Shareholder returns have been supported by consistent dividends and share repurchases, though the company's valuation indicates some market skepticism reflected in the recent price movement."

Revenue Growth

Neutral

Current revenue growth is stagnating, with limited forward momentum noted.

Profitability

Neutral

Negative EPS and net margin highlight profitability challenges.

Cash Flow Quality

Good

Strong operating cash flow and free cash flow support investor distributions.

Leverage & Balance Sheet

Caution

High net debt and significant liabilities highlight leverage concerns.

Shareholder Returns

Positive

Robust dividends and share repurchases enhance shareholder value despite earnings volatility.

Analyst Sentiment & Valuation

Neutral

Moderate analyst price targets reflect mixed sentiment, with cautious optimism.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Colgate-Palmolive delivered stronger-than-expected Q4 and grew sales, margins, EPS, and free cash flow for 2025 despite inflation, tariffs, and weak categories. Momentum improved exiting the year, with broad-based organic growth and strong performance at Hill’s. Management launched a 2030 strategy focused on science-led innovation, omnichannel demand generation, digital/AI, and supply chain optimization, funded by a new productivity program and FX flexibility. Outlook for 2026 is cautious with 1–4% organic growth guidance reflecting low category growth, U.S. softness, currency/geopolitical risks, and potential promotional intensity, offset by emerging market strength, premiumization, and a robust innovation pipeline.

Growth

  • Q4 organic sales growth across all four categories; sequential improvement in every division except North America
  • Company underlying Q4 organic growth >3% excluding private label; modest volume growth excluding Prime 100 acquisition and private label exit
  • Emerging markets outpaced developed markets; Mexico and Brazil strong, India returned to growth
  • Hill’s ex-private-label organic growth >5% with positive volume; share gains in Prescription Diet
  • E-commerce share gains in China and improving trends at Hawley & Hazel driven by new super-premium product

Business Development

  • Completed 2025 strategy, adding ~$5B in sales
  • Prime 100 acquisition included in reported results; planned exit of private label at Hill’s (360 bps volume headwind)
  • Launched super-premium dual-chamber product for Hawley & Hazel online in China
  • Announced Strategic Growth & Productivity Program (SGPP) to fund priorities and streamline organization
  • Gained additional shelf space for Hill’s exiting 2025

Financials

  • 2025 delivered growth in organic sales, net sales, gross profit, base business EPS, and free cash flow despite raw material inflation, tariffs, and softer categories
  • 2026 guidance: net sales and organic sales growth 1%–4% (range reflects category uncertainty)
  • FX: expected low single-digit revenue tailwind in 2026 (primarily 1H); Europe biggest marginal benefit; LatAm currencies stronger recently
  • Hill’s: private label exit was a 360 bps drag on volume; underlying volume grew ~2%
  • Focus on investing incremental flexibility (including FX) back into the business while contributing to EPS

Capital & Funding

  • Using FX benefit and SGPP to fund brand building, innovation, and capability investments
  • Ongoing use of revenue growth management (RGM) and pricing to navigate currency and cost volatility
  • Supply chain investments to enhance efficiency and support innovation/personalization at scale

Operations & Strategy

  • New 2030 strategy centered on: global brands; science-based innovation across price tiers; best-in-class omnichannel demand generation; digital/data/analytics/AI; and supply chain optimization
  • Supply chain optimization via predictive analytics and automation to improve utilization, service levels, and quality
  • Cultural focus as competitive advantage with aligned KPIs and talent development
  • Transferring China omni-demand playbook globally, including to Hawley & Hazel
  • Premiumization strategy in Asia and continued investment in therapeutic pet nutrition

Market & Outlook

  • Categories stabilized but at low growth (~1.5%–2.5%); U.S. volumes pressured and not assumed to rebound materially near term
  • Western Europe improving; Eastern Europe weak (notably Poland)
  • Latin America remains volatile despite strong Mexico and Brazil; Andina and Central America still challenged
  • Asia improving; Chinese New Year timing expected to support Q1; Hawley & Hazel improving but not fully recovered
  • Guidance framework: low end if categories weaken, mid if stable, high end if categories strengthen

Risks Or Headwinds

  • Low category growth could trigger higher promotions and competitive intensity
  • FX volatility (historically adverse 8 of last 10 years) despite near-term tailwind
  • Geopolitical and tariff risks, particularly in Latin America
  • U.S. market sluggish with negative volumes in some core categories and retailer inventory pressure
  • Eastern Europe softness; ‘Buy Canadian’ impact in Canada for pet; slower pet adoptions weighing on category
  • Raw material cost inflation remains a consideration

Sentiment: CAUTIOUS

Note: This summary was synthesized by AI from the CL Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (CL)

© 2026 Stock Market Info — Colgate-Palmolive Company (CL) Financial Profile